Oramed Pharmaceuticals (ORMP) Cash from Investing Activities Growth (5y) (2015 - 2021)
Oramed Pharmaceuticals (ORMP) Cash from Investing Activities Growth (5y) (2015 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
| Date | Value |
|---|
| Nov 30, 2021 |
-95.87% |
| Aug 31, 2021 |
-22.53% |
| May 31, 2021 |
26.95% |
| Feb 28, 2021 |
23.65% |
| Nov 30, 2020 |
7.95% |
| May 31, 2020 |
-41.27% |
| Feb 29, 2020 |
24.83% |
| Nov 30, 2019 |
13.86% |
| Aug 31, 2019 |
96.07% |
| May 31, 2019 |
105.37% |
| Feb 28, 2019 |
16.11% |
| Nov 30, 2018 |
82.90% |
| Aug 31, 2018 |
-29.25% |
| May 31, 2018 |
105.59% |
| Feb 28, 2018 |
33.09% |
| Nov 30, 2017 |
-67.87% |
| Aug 31, 2017 |
164.83% |
| May 31, 2017 |
50.62% |
| Feb 28, 2017 |
16.88% |
| Nov 30, 2016 |
-57.38% |
